Lara Best

Associate Professor & Program Director, Residency Program

Lara Best

Email: kelly.daye@nshealth.ca
Phone: 902-473-6185
Fax: 902-473-7205
Mailing Address: 
Department of Radiation Oncology
Dalhousie University
Rm 2200, Main Floor, NSCC
5820 University Avenue
Halifax, B3H 1V7
 

Clinical sites

Head and Neck, Skin, CNS tumors and Benign conditions

Education

  • MD (Queen's University)
  • FRCPC (Western University)
  • MEd (Acadia University)
  • FRANZCR (Australia)

Research Interests

  • Medical education
  • Skin cancer
  • 3D-bolus

Administrative Roles

  • Radiation Oncology Residency Program Director
  • TROG Independent Data and Safety Monitory Committee (IDSMC), committee member

Awards and honours

  • RANZCR Graduation Ceremony, Declaration of Geneva presenter
  • Governor General’s Award for Academic Excellence, Acadia University, 2019
  • Teacher of the Year, Department of Radiation Oncology 2019, 2018.

Recent publications

  • Tan VS, Best L. Delayed treatment of retroclival meningioma in a 70-year-old female. Cureus 2020; 12(1): e6579.
  • Best L, Sengupta A, Murphy RJ, de Metz C, Trotter T, Loewen SK, Ingledew PA, Sargeant J. Transition to practice in radiation oncology: mind the gap. Radiother Oncol 2019; 138: 126-31.
  • Dahn H, Watts K, Best L, Bowes D. Attitudes towards research during residency training: a survey of Canadian radiation oncology residents and program directors. J Cancer Educ. Accepted June 2019.
  • Moran K, Sinclair L, Freire S, Peters L, Bowes D, Best L, Cherpak AJ, Darling M, Day T, Trask J, Ilie G. Describing a process for creating a patient visible quality educational display to increase patient engagement in Radiation Oncology throughout the Canadian maritime provinces. J Cancer Educ 2018. Epub ahead of print.
  • Dahn H, Watts K, Best L, Bowes D. Transition to practice: creation of a transitional rotation for radiation oncology residents. Can Med Educ J;2018: 9(3): e89-96.
  • Best L, de Metz C, Olivotto IA, Roy I, Whelan T, Arsenault J, Brundage M. Radiation therapy quality indicators for invasive breast cancer. Radiother Oncol 2017;123(2): 288-93.